Clinvest (United States)

Recent papers from Clinvest (United States)

1. Isolated levator palpebrae superioris enlargement as the sole harbinger of primary orbital lymphomaOrbit · 2026
2. Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label StudyPain and Therapy · 2024
3. Efficacy of fluralaner chewable tablets (Bravecto®) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogsParasites & Vectors · 2023
4. Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administrationPharmacokinetics and Pharmacodynamics · 2023
5. Rethinking organizational strategies and policies for employee retention in the wake of the migration crisisCorporate and Business Strategy Review · 2023
6. Efficacy of fluralaner chewable tablets (Bravecto ® ) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs2022
7. Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk ReductionClinical Infectious Diseases · 2022
8. An extension of the QWERTY effect: Not just the right hand, expertise and typeability predict valence ratings of wordsPsychology of Language and Communication · 2022
9. Pharmacokinetic and Bioequivalence Study of Telzap AM® (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis® (Telmisartan) and Norvask® (Amlodipine) in Healthy SubjectsDrug development & registration · 2020
10. Physician’s Perception Versus Patient’s Actual Incidence of Drug Non-adherence in Chronic IllnessesCureus · 2017
11. A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraineThe Journal of Headache and Pain · 2017
12. Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraineThe Journal of Headache and Pain · 2017
13. Chronic migraine headache prevention with noninvasive vagus nerve stimulationNeurology · 2016
14. Long‐Term Efficacy of a Double‐Blind, Placebo‐Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx 360 ® Device for Treatment of Chronic MigraineHeadache The Journal of Head and Face Pain · 2015
15. A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With T x360 ® as Acute Treatment for Chronic MigraineHeadache The Journal of Head and Face Pain · 2014
16. Effect of noninvasive vagus nerve stimulation on acute migraine: An open-label pilot studyCephalalgia · 2014
17. Treatment of Chronic Migraine: A 3‐Month Comparator Study of Naproxen Sodium vs SumaRT / N apHeadache The Journal of Head and Face Pain · 2013
18. Uncovering Latent Deficits Due to Mild Traumatic Brain Injury by Using Normobaric Hypoxia StressFrontiers in Neurology · 2013
19. Evaluation of Sumatriptan‐Naproxen in the Treatment of Acute Migraine: A Placebo‐Controlled, Double‐Blind, Cross‐Over Study Assessing Cognitive FunctionHeadache The Journal of Head and Face Pain · 2012
20. The Development of a Survey to Measure Completeness of Response to Migraine TherapyHeadache The Journal of Head and Face Pain · 2012